BTIG Reiterates Buy on Coya Therapeutics, Maintains $16 Price Target
Coya Therapeutics Inc COYA
$5.08
▼ -1.93%
($-0.10)
Open
$5.19
Prev Close
$5.18
Day Range
$5.02 – $5.24
52W Range
$3.71 – $7.75
Market Cap
$119.17M
Beta
0.58
EPS (TTM)
$-1.07
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-12-29 |
| Shares Out. | 23,460,000 |
| Website | coyatherapeutics.com/ ↗ |
| Phone | 18009279800 |
| Employees | 8 |
| Revenue | $243,745 |
| Gross Profit | $243,745 |
| Net Income | -$6.6M |
| Free Cash Flow | -$15.7M |
| Total Assets | $47.3M |
| Total Liabilities | $4.0M |
| Equity | $43.3M |
About Coya Therapeutics Inc
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Coya Therapeutics Inc is a publicly traded company under the ticker symbol COYA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-09-01)